• Product NameAdefovir dipivoxil
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityAdefovir dipivoxil, previously called bis-POM PMEA, with trade names Preveon and Hepsera, is an orally-administered acyclic nucleotide analog reverse transcriptase inhibitor (ntRTI) used for treatment of hepatitis B. It is ineffective against HIV-1. Adefovir dipivoxil is the diester prodrug of adefovir.
• Target NameOthers inhibitor; Reverse Transcriptase inhibitor
• CAS No. 142340-99-6
• Calculated MW 501.47
• Formulation C20H32N5O8P
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C
  Pathways:Microbiology&virology; Others
  Receptor:Protein P; Reverse Transcriptase; Reverse Transcriptase
  Boling pt:
  Melting pt:98-102C
  Solubility:Ethanol: 100 mg/mL (199.41 mM); DMSO: 100 mg/mL (199.41 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Julander JG, et al. Antiviral Res, 2002, 55(1), 27-40.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting